Shanghai EpimAb Biotherapeutics Co., Ltd.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma | aggressive B-cell non-Hodgkin lymphoma | Recruiting | Phase 1 / Phase 2 | 2026-09-01 | NCT07432022 | |
| EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Phase 1 | 2026-06-16 | NCT07649655 | |
| A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors. | Locally Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-06-15 | NCT07607054 | |
| Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-03-03 | NCT07314294 |